Core Viewpoint - XunCe (03317) has seen a significant increase in its stock price, rising over 16% to a high of 72 HKD, which is a 50% increase from its IPO price of 48 HKD [1] Group 1: Company Developments - XunCe announced a non-binding strategic cooperation framework agreement with Jin Yong Investment on January 13, aimed at advancing real-time data infrastructure to support digital transformation in investment research, trading, and risk management [1] - The collaboration also focuses on promoting innovation and commercialization of technology products related to wealth management [1] Group 2: Market Context - The review period for the Hang Seng Composite Index's semi-annual assessment ended on December 31, 2025, with a new round of adjustments to the Hong Kong Stock Connect list expected to be announced after the market closes on February 20, 2026, and implemented after the market closes on March 6, 2026 [1] - Longjiang Securities has published a report predicting that 47 stocks will meet the criteria for inclusion in the Hong Kong Stock Connect list, with XunCe likely to be among them [1]

Group 1 - The core viewpoint of the article highlights that Xunce (03317) has seen a significant stock price increase of over 16%, reaching a high of 72 HKD, which is a 50% rise from its IPO price of 48 HKD [1] - As of the report, the stock is trading at 70.5 HKD with a trading volume of 12.64 million HKD [1] - Xunce announced a non-binding strategic cooperation framework agreement with Jinyong Investment on January 13, aimed at advancing real-time data infrastructure to support digital transformation in investment research, trading, and risk management [1] Group 2 - The strategic cooperation also focuses on promoting innovation and commercialization of technology products related to wealth management [1] - The Hang Seng Composite Index's semi-annual review period ended on December 31, 2025, with a new adjustment to the Hong Kong Stock Connect list expected to be announced after the market closes on February 20, 2026, and implemented after the market closes on March 6, 2026 [1] - Longjiang Securities has published a report predicting that 47 stocks will meet the criteria for inclusion in the Hong Kong Stock Connect list, with Xunce likely to be among them [1]

Core Viewpoint - XunCe (03317) has seen a significant increase in stock price, rising over 6% and reaching a new high of 68 HKD, driven by the announcement of a strategic cooperation framework agreement with Jin Yong Investment [1] Group 1: Strategic Cooperation - The strategic cooperation agreement with Jin Yong Investment is non-binding and aims to advance the development of real-time data infrastructure to support digital transformation in investment research, trading, and risk management [1] - The collaboration will focus on the innovation and commercialization of technology products related to wealth management, including the application of real-time data technology in smart valuation, risk monitoring, and compliance [1] - The partnership will explore investment opportunities in data infrastructure, artificial intelligence, and other fintech-related projects to foster a "data + capital" ecosystem [1] Group 2: Financial Implications - The board believes that the strategic cooperation with Jin Yong Investment will provide further opportunities for diversified revenue sources for the company [1] - The agreement is considered to be in the best interests of the company and its shareholders [1]

Core Viewpoint - XunCe (03317) continues to rise over 6%, reaching a new high of 68 HKD, driven by a strategic cooperation framework agreement with Jin Yong Investment aimed at enhancing digital transformation in investment research and wealth management [1] Group 1: Company Developments - XunCe's stock price increased by 6.88%, trading at 66.8 HKD with a transaction volume of 4.782 million HKD [1] - The company announced a non-binding strategic cooperation framework agreement with Jin Yong Investment on January 13 [1] Group 2: Strategic Goals - The strategic cooperation aims to advance real-time data infrastructure to support digital transformation in investment research, trading, and risk management [1] - The collaboration will promote innovation and commercialization of technology products related to wealth management, including applications of real-time data technology in smart valuation, risk monitoring, and compliance [1] - The partnership will explore investment opportunities in data infrastructure, artificial intelligence, and other fintech projects to cultivate a "data + capital" ecosystem [1] Group 3: Financial Implications - The board believes that the strategic cooperation with Jin Yong Investment will provide further opportunities for diversified revenue sources for the company [1] - The agreement is considered to be in the best interests of the company and its shareholders [1]

Core Viewpoint - The company has entered into a non-binding strategic cooperation framework agreement with Jinyong Investment Limited to explore potential synergies and enhance its service offerings in the financial technology sector [1][3]. Group 1: Strategic Cooperation Objectives - The strategic cooperation aims to advance real-time data infrastructure to support digital transformation in investment research, trading, and risk management [1][3]. - It seeks to promote innovation and commercialization of wealth management-related technology products, including the application of real-time data technology in smart valuation, risk monitoring, and compliance [1][3]. - The partnership will explore investment opportunities in data infrastructure, artificial intelligence, and other fintech-related projects to foster a "data + capital" ecosystem [1][3]. - Jinyong Investment may provide business services such as business development consulting, investment and financial consulting, cash management, and/or asset allocation services upon further agreements [1][3]. Group 2: Business Background - Jinyong Investment and its subsidiaries primarily engage in providing investment management services and conducting strategic direct investment activities [1][3]. - The board believes that the strategic cooperation will offer the company further opportunities for diversified revenue sources and is in the best interest of the company and its shareholders [1][3].

Core Viewpoint - The company has entered into a non-binding strategic cooperation framework agreement with Jinyong Investment Limited to enhance its capabilities in real-time data infrastructure and digital transformation in investment research, trading, and risk management [1] Group 1: Strategic Cooperation Goals - The strategic cooperation aims to advance the development of real-time data infrastructure to support digital transformation in investment research, trading, and risk management [1] - It seeks to promote innovation and commercialization of wealth management-related technology products, including the application of real-time data technology in smart valuation, risk monitoring, and compliance [1] - The partnership will explore investment opportunities in data infrastructure, artificial intelligence, and other fintech-related projects to foster a "data + capital" ecosystem [1] Group 2: Potential Business Services - Following further agreements, Jinyong Investment may provide business services such as business development consulting, investment and financial consulting, cash management, and/or asset allocation services [1] Group 3: Business Diversification - The board believes that the strategic cooperation with Jinyong Investment will provide opportunities for further diversification of revenue sources for the company [1] - The agreement is considered to be in the best interests of the company and its shareholders [1]

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性或完整性亦不發表 任何聲明，並明確表示，概不對因本公告全部或任何部份內容而產生或因倚賴該等內容而引致的任何損失承擔任 何責任。 Shenzhen Xunce Technology Co., Ltd. 深圳迅策科技股份有限公司 本公告乃由深圳迅策科技股份有限公司（「本公司」）自願作出，旨在使本公司股東（「股 東」）及潛在投資者知悉本公司之最新業務發展。 戰略合作 本公司董事會（「董事會」）欣然宣佈，鑒於本公司與金湧投資有限公司（「金湧投資」， 於開曼群島註冊成立之有限公司，其股份於香港聯合交易所有限公司上市（股份代號： 1328））之間的潛在戰略契合，本公司已於2026年1月13日與金湧投資訂立不具法律約束 力之戰略合作框架協議（「戰略合作協議」）。 雙方的戰略合作旨在：(i)推進實時數據基礎設施的發展，以支持投資研究、交易及風險 管理的數字化轉型；(ii)促進財富管理相關科技產品的創新及商業化，包括實時數據技 術在智能估值、風險監測及合規方面的應用，以及為不同行業客戶開發標準化SaaS解決 方案；(iii)探索數據基礎設施、人工 ...

Core Viewpoint - The article provides an overview of recent IPO activities across Hong Kong, the US, and A-shares, highlighting several companies preparing for their public listings and their respective market positions. Group 1: Muxi Integrated Circuit - Muxi Integrated Circuit (Shanghai) Co., Ltd. officially listed on the Shanghai Stock Exchange's Sci-Tech Innovation Board on December 17, 2025, with the stock code "688802" [3] - Founded in 2020, Muxi is a leading domestic high-performance general-purpose GPU product company, focusing on the research, design, and sales of GPUs for AI training, inference, general computing, and graphics rendering [3] - Muxi's GPU products have achieved cumulative sales of over 25,000 units by the end of March 2025, with a revenue compound growth rate of 4074.52% over the past three years, and revenue of 915 million yuan in the first half of this year [5] Group 2: Woan Robotics - Woan Robotics (Shenzhen) Co., Ltd. plans to officially list on the Hong Kong Stock Exchange on December 30, 2025, with the stock code "6600" [7] - The company aims to become the "first stock of AI-embodied household robots," with an IPO market valuation between 14 billion and 18 billion HKD, raising up to 1.8 billion HKD [8] - Woan Robotics is recognized as the only company globally to comprehensively layout AI-embodied household robot systems, holding an 11.9% market share in the sector by 2024 [10] Group 3: Xunce Technology - Xunce Technology plans to list on the Hong Kong Stock Exchange on December 30, 2025, with the stock code "3317," marking it as the first company in China's AI data sector to complete an IPO [12] - The company aims to raise up to 1.2375 billion HKD through its IPO, with a focus on real-time data infrastructure and analysis solutions [12] - Xunce Technology's real-time data solutions are noted for their speed and consistency, optimizing business efficiency and flexibility [14] Group 4: InSilico Medicine - InSilico Medicine plans to list on the Hong Kong Stock Exchange on December 30, 2025, with the stock code "3696," aiming to raise up to 2.3 billion HKD [16] - The company is recognized as the largest biotech IPO in Hong Kong this year, with a focus on AI-driven drug development across various industries [17] - InSilico's core asset, Rentosertib, is a first-in-class candidate drug for idiopathic pulmonary fibrosis, showcasing the company's innovative capabilities [18] Group 5: Linqingxuan - Linqingxuan Cosmetics Group plans to list on the Hong Kong Stock Exchange on December 30, 2025, with the stock code "2657," aiming to raise over 1 billion HKD [21] - The company is positioned as the leading high-end domestic skincare brand in China, with a complete product matrix in anti-wrinkle and firming skincare [22] - Linqingxuan ranks first among all domestic high-end skincare brands in China by retail revenue in 2024 [22] Group 6: 51WORLD - 51WORLD plans to list on the Hong Kong Stock Exchange on December 30, 2025, with the stock code "6651," aiming to become the "first stock of Physical AI" [24] - The company has established a comprehensive technology capability in Physical AI, with products applied in various industries globally [24] - 51WORLD's revenue has shown significant growth, with a 63.6% increase in the first half of this year compared to the same period last year [26] Group 7: Qingsong Health Group - Qingsong Health Group plans to list on the Hong Kong Stock Exchange on December 23, 2025, with the stock code "2661," aiming to raise over 600 million HKD [28] - The company operates as a one-stop digital health and insurance service platform, covering various health-related services [28] - Qingsong Health Group's revenue has grown significantly, with an 84.7% increase in the first half of this year compared to the previous year [29] Group 8: Biran Technology - Biran Technology has passed the hearing for its listing on the Hong Kong Stock Exchange, focusing on general intelligent computing solutions [31] - The company has shown strong growth potential, with significant sales agreements in place and a focus on AI data centers and telecommunications [32] Group 9: Zhipu Technology - Zhipu Technology has passed the hearing for its listing on the Hong Kong Stock Exchange, aiming to become the "first stock of global large models" [35] - The company has achieved significant revenue growth, with a compound annual growth rate of 130% from 2022 to 2024 [36] Group 10: Tiandu Intelligent Chip - Tiandu Intelligent Chip has passed the hearing for its listing on the Hong Kong Stock Exchange, focusing on general-purpose GPU chips [38] - The company has seen a significant increase in customer numbers and product shipments, reflecting strong market recognition [39]

Core Viewpoint - XunCe Technology is a leading provider of real-time data infrastructure and analytical solutions in China, focusing on seamless deployment of data solutions across various environments [3][4]. Industry Overview - The real-time data infrastructure and analytics market in China is projected to reach RMB 18.7 billion in 2024, accounting for 4.5% of the total data infrastructure and analytics market [3]. - The asset management sector represents 11.2% of the real-time data infrastructure and analytics market in China, with XunCe Technology holding a leading market share of 11.6% [4]. Company Performance - XunCe Technology's revenue for the fiscal years 2022, 2023, and 2024 is reported as approximately RMB 288 million, RMB 530 million, and RMB 632 million respectively, with a loss of RMB 96.5 million, RMB 63.4 million, and RMB 97.8 million for the same years [4][5]. - For the six months ending June 30, 2024, the company achieved revenue of approximately RMB 283 million, with a loss of about RMB 97.8 million [5]. Product Offering - The core product of XunCe Technology is a unified data platform that enables the collection, cleaning, management, analysis, and governance of heterogeneous data from multiple sources within milliseconds to seconds [3]. - The company's solutions are designed to optimize various aspects of the asset management lifecycle, including portfolio monitoring, order execution, valuation, risk management, and compliance [4].

Core Viewpoint - The company, Zhixun (03317), is set to launch an IPO from December 18 to December 23, 2025, aiming to issue 22.5 million shares at a price range of HKD 48-55 per share, with a significant portion allocated for international investors [1] Group 1: Company Overview - The company is a provider of real-time data infrastructure and analytical solutions in China, offering seamless deployment of data technology solutions across various industries [1] - The real-time data infrastructure market in China is projected to reach RMB 18.7 billion in 2024, representing 4.5% of the total data infrastructure and analysis market [1] - The company ranks fourth in the real-time data infrastructure segment with a market share of 3.4% [1] Group 2: Product and Market Position - The core product is a unified data platform that processes heterogeneous data from multiple sources in milliseconds to seconds, enabling immediate decision-making and analysis [2] - The company started in the asset management sector, which accounts for 11.2% of the real-time data infrastructure market in China, and it holds the top position in this segment with an 11.6% market share [2] Group 3: Client Base and Industry Challenges - The asset management industry is noted for its complexity and high demands for data accuracy and timeliness, and the company’s solutions are adaptable to various other sectors [3] - The company’s clients will include diverse industries beyond asset management, such as financial services, urban management, manufacturing, and telecommunications [3] - The real-time data infrastructure market faces intense competition, pricing pressures, and rapid technological advancements [3] Group 4: Funding and Use of Proceeds - The company estimates a net proceeds of approximately HKD 1.04 billion from the global offering, assuming a share price of HKD 51.50 [4] - Approximately 80% of the net proceeds will be allocated for ongoing and future R&D of the company’s solutions, 10% for enhancing marketing capabilities, and the remaining 10% for working capital and general business purposes [4]